Fig. 2From: Transcutaneous supraorbital neurostimulation in “de novo” patients with migraine without aura: the first Italian experiencePercentage of patients having at least 50 % reduction of monthly migraine attacks and migraine days between run-in and 60-days of treatmentBack to article page